Clinical Trial Update: Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DP-R207 tablet to CRESTOR tablet in adults with primary hypercholesterolemia to assess efficacy and safety; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR Tablet (rosuvastatin calcium)
• DP-R207 Tablet

Snippet

Sponsor: Alvogen Korea | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED